Steven Jungles
Director/Board Member chez Brammer Bio LLC
Profil
Steven Jungles is currently a Director at Brammer Bio LLC.
Prior to this, he was a Director at Brammer Biopharmaceuticals LLC.
He also held the position of Manager-Process Development & Clinical Production at Somatix Therapy Corp.
from 1993 to 1997.
Additionally, he was Vice President-Supply Chain at BioMarin Pharmaceutical, Inc. and Senior Vice President-Technical Operations at Ultragenyx Pharmaceutical, Inc. from 2011 to 2015.
He was also the Chief Technical Operations Officer & Senior VP at Inozyme Pharma, Inc. Mr. Jungles received his undergraduate degree from the University of Iowa.
Postes actifs de Steven Jungles
| Sociétés | Poste | Début |
|---|---|---|
Brammer Bio LLC
 Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Anciens postes connus de Steven Jungles
| Sociétés | Poste | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01/04/2015 |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Corporate Officer/Principal | 01/01/1997 |
| INOZYME PHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
Brammer Biopharmaceuticals LLC
 Brammer Biopharmaceuticals LLC BiotechnologyHealth Technology Brammer Biopharmaceuticals LLC provides contract development and manufacturing services. Its services include process development, gene therapy and cell therapy manufacturing. The company was founded by Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Lexington, MA. | Director/Board Member | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Formation de Steven Jungles
| University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
Brammer Biopharmaceuticals LLC
Brammer Biopharmaceuticals LLC BiotechnologyHealth Technology Brammer Biopharmaceuticals LLC provides contract development and manufacturing services. Its services include process development, gene therapy and cell therapy manufacturing. The company was founded by Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Lexington, MA. | Health Technology |
Brammer Bio LLC
Brammer Bio LLC Pharmaceuticals: MajorHealth Technology Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA. | Health Technology |
